Food Introduction for Risk Reduction, Support Tolerance: Behavioral Intervention for Toddler Eating Success (FIRST BITES)
FIRST BITES (Food Introduction for Risk Reduction, Support Tolerance: Behavioral Intervention for Toddler Eating Success): A Multi-Site Community-Based Translational Study of Early Peanut and Egg Introduction With Behavioral Reinforcement
The goal of this clinical trial is to evaluate the feasibility, acceptability, perceived safety, and adherence outcomes of FIRST BITES (Food Introduction for Risk Reduction, Support Tolerance: Behavioral Intervention for Toddler Eating Success), a supervised, community-based early peanut introduction model, in caregiver-infant dyads.
The main questions it aims to answer are:
- Can eligible caregiver-infant dyads be successfully recruited to and retained in community-based peanut introduction events, and do caregivers find the feeding event, educational materials, and intervention approach acceptable?
- Does education plus structured behavioral reinforcement improve adherence to peanut feeding recommendations, caregiver self-efficacy, and caregiver anxiety related to early peanut introduction compared with education alone?
Researchers will compare education alone with education plus behavioral reinforcement to determine whether behavioral reinforcement supports continued peanut feeding and improves caregiver confidence following peanut introduction.
Participants will:
- Attend a supervised community-based peanut introduction event.
- Receive education about early peanut introduction.
- Be randomized to receive either education alone or education plus behavioral reinforcement following the feeding event.
- Complete surveys regarding peanut feeding practices, caregiver self-efficacy, anxiety related to peanut introduction, and perceptions of feasibility, acceptability, and safety.
- Participate in follow-up assessments during the 6-week intervention period and at 3 months after enrollment.
- Some participants may be invited to complete qualitative interviews regarding barriers and facilitators to early peanut introduction.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Arkansas
-
Little Rock, Arkansas, 미국, 72205
- University of Arkansas for Medical Sciences/Arkansas Children's Research Institute
-
연락하다:
- Amy Scurlock, MD
- 이메일: ScurlockAmyM@uams.edu
-
-
Connecticut
-
New Haven, Connecticut, 미국, 06520
- Yale University
-
연락하다:
- Stephanie Leeds, MD
- 이메일: stephanie.leeds@yale.edu
-
-
Texas
-
Dallas, Texas, 미국, 75235
- UTSW/Children's Medical Center
-
수석 연구원:
- John Bird, MD
-
연락하다:
- Study Coordinator
- 이메일: meilyn.madrigalbriceno@utsouthwestern.edu
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
-
Caregivers:
- You are 18 years old or older.
- You are the infant's parent or legal guardian.
- You are able to give permission for yourself and your infant to participate in the study.
- You can speak and read English.
- You are interested in introducing peanut-containing foods to your infant and continuing to feed peanut regularly.
- You are willing to attend the supervised peanut feeding event and complete study follow-up activities.
- You are willing to receive study-related reminders and communications by phone, email, or text message.
-
Infants:
- They are 4 to 8 months old at the time they join the study.
- They are developmentally ready to safely eat foods by mouth.
- They have never eaten peanut before.
- The study team determines that they are an appropriate candidate for supervised peanut introduction.
-
Advisory Panel Participants:
- You are 18 years of age or older.
- You are able to provide informed consent.
- You have experience related to one or more of the following: Community feeding events, Behavioral interventions, Pediatric allergy care, Community medical practice, Implementation or program development, Health equity, Participant recruitment and retention, Community engagement
- You are willing to participate in a virtual discussion group or feedback session that may be audio recorded.
Exclusion Criteria:
-
Caregiver-Infant Pairs
- The infant has already eaten peanut.
- The infant has a known peanut allergy or has been diagnosed with a peanut allergy by a doctor.
- The infant has had a previous reaction that may have been caused by a peanut allergy.
- The infant has a diagnosed feeding disorder.
- The infant has a medical, developmental, or feeding condition that could make peanut introduction unsafe or make it difficult to participate in the study.
- The caregiver is not the infant's parent or legal guardian.
- The caregiver is unable or unwilling to provide consent for participation.
- The caregiver is unable to participate in study activities and follow-up assessments in English.
- The caregiver or infant has another condition or circumstance that the study doctor believes would make participation unsafe, impractical, or not in their best interest.
-
Advisory Panel Participants:
- You are unable or unwilling to provide informed consent.
- You are unable to participate in the virtual discussion group or feedback session.
- The study team determines that a conflict of interest, role limitation, or other circumstance makes participation inappropriate.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 방지
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
다른: Education Alone
|
Educational materials provide guidance on peanut feeding practices and recommendations for continued peanut consumption following the initial supervised introduction. |
|
다른: Education plus behavioral reinforcement
|
In addition to the supervised community-based peanut introduction event and educational materials, reinforcements will also be added. Behavioral reinforcement may include reminder messages, prompts, and supportive communications intended to encourage adherence to peanut feeding recommendations and increase caregiver confidence with continued peanut introduction. |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Recruitment, Attendance, Retention, Assessment Completion, and Engagement Rates and Feasibility of Intervention Measure (FIM) Scores
기간: Recruitment through Week 6 post-community feeding event (end of intervention)
|
Feasibility will be assessed using recruitment, enrollment, attendance, retention, and engagement metrics, including the number of families expressing interest, screened, eligible, enrolled, attending a community feeding event, completing supervised peanut introduction, randomized, completing the 6-week assessment, and completing the 3-month assessment. Engagement will be assessed using response rates during weekly text-message check-ins among participants assigned to behavioral reinforcement. Feasibility will also be assessed using the Feasibility of Intervention Measure (FIM), a 4-item participant-reported measure. Total scores range from 4 to 20, with higher scores indicating greater perceived feasibility of the intervention. |
Recruitment through Week 6 post-community feeding event (end of intervention)
|
|
Acceptability of Community Feeding Events and Behavioral Reinforcement Strategy Measured by Acceptability of Intervention Measure (AIM) Scores and Qualitative Interview Findings
기간: 6 weeks post-community feeding event (end of intervention)
|
Acceptability will be assessed using the Acceptability of Intervention Measure (AIM) and qualitative caregiver interview data. The AIM will assess caregiver perceptions of the acceptability of the community feeding event and, for participants assigned to the intervention arm, the 6-week behavioral reinforcement text message program. The AIM is a 4-item participant-reported measure with total scores ranging from 4 to 20, with higher scores indicating greater acceptability. Qualitative interviews will assess caregiver perceptions of the acceptability of the community feeding event, educational materials, peanut preparation demonstration, supervised feeding process, behavioral reinforcement strategy, and follow-up procedures. Interview data will be analyzed to identify caregiver-reported barriers, facilitators, perceived strengths, and suggested refinements. |
6 weeks post-community feeding event (end of intervention)
|
|
Caregiver-Reported Comfort, Staff-Observed Safety Events, Adverse Events, Emergency Medical Interventions, and Safety Concerns During Supervised Peanut Introduction
기간: Community feeding event (Day 0), Week 6 post-community feeding event, and Month 3 follow-up.
|
Perceived safety will be assessed using caregiver-reported comfort with the supervised peanut introduction process, study staff observations during the community feeding event, documentation of observed or reported symptoms and adverse events, emergency medication administration, emergency medical services activation, and caregiver-reported safety concerns. Safety outcomes will be summarized descriptively overall and by study site. |
Community feeding event (Day 0), Week 6 post-community feeding event, and Month 3 follow-up.
|
|
Caregiver-Reported Peanut Offering, Peanut Ingestion, Feeding Frequency, and Peanut Protein Consumption
기간: Baseline, weekly during Weeks 1-6 for participants assigned to behavioral reinforcement, 6 weeks post-community feeding event, and 3 months post-enrollment.
|
Adherence to ongoing peanut feeding will be assessed using caregiver-reported peanut offering and ingestion. Measures will include whether peanut was offered to the infant, whether the infant ingested peanut, frequency of peanut offering and ingestion, and estimated quantity of peanut protein consumed. Data will be collected at baseline, 6 weeks, and 3 months. For participants assigned to the behavioral reinforcement arm, weekly text-message check-ins during the 6-week intervention period will also be used to assess week-by-week adherence patterns. |
Baseline, weekly during Weeks 1-6 for participants assigned to behavioral reinforcement, 6 weeks post-community feeding event, and 3 months post-enrollment.
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Caregiver Self-Efficacy Measured by the PROMIS General Self-Efficacy Scale
기간: Baseline (Day 0/community feeding event), Week 6 post-community feeding event, and Month 3 follow-up
|
Caregiver self-efficacy will be assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) General Self-Efficacy Scale, a 4-item caregiver-reported measure, and additional study-specific items related to caregiver confidence in introducing and maintaining peanut in the infant's diet. PROMIS General Self-Efficacy Scale total scores range from 4 to 20, with higher scores indicating greater self-efficacy and confidence in managing challenges related to infant peanut introduction and feeding. |
Baseline (Day 0/community feeding event), Week 6 post-community feeding event, and Month 3 follow-up
|
|
Caregiver Anxiety Measured by PROMIS Caregiver Anxiety Scale Scores
기간: Baseline (Day 0/community feeding event), Week 6 post-community feeding event, and Month 3 follow-up
|
Caregiver anxiety will be assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Caregiver Anxiety Scale, an 8-item caregiver-reported measure. Total scores range from 8 to 40, with higher scores indicating greater anxiety and more severe anxiety symptoms. Scores will be summarized and compared across study assessment time points. |
Baseline (Day 0/community feeding event), Week 6 post-community feeding event, and Month 3 follow-up
|
공동 작업자 및 조사자
협력자
협력자
수사관
수사관
- 수석 연구원: John Bird, MD, University of Texas Southwestern Medical Center
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
기타 연구 ID 번호
- STU20261350
- FP00043943 (기타 보조금/기금 번호: American College of Allergy Asthma and Immunology)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
Individual participant data will not be made available to external researchers. Data sharing will be limited to authorized study personnel at participating sites as necessary for study conduct, safety monitoring, regulatory compliance, and reporting.
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .